<div id="readability-page-1"><p>Huatai Securities analyst  maintained a Buy rating on JD Health International, Inc. yesterday and set a price target of HK$65.20.</p><h3>Claim 70% Off TipRanks Premium</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul>  <p>In addition to Huatai Securities, JD Health International, Inc. also received a Buy from TipRanks – PerPlexity’s PerPlexity Health Care HK in a report issued on March 8. However, on the same day, TipRanks – xAI downgraded JD Health International, Inc. (HKEX: 6618) to a Hold.</p></div>

06618

09618

<p>Huatai Securities has maintained a Buy rating on JD Health International, Inc. (6618) with a price target of HK$65.20. Additionally, TipRanks also issued a Buy rating for the company, while on the same day, another report downgraded it to a Hold.</p>

- Huatai Securities analyst maintained a Buy rating on JD Health International, Inc. with a price target of HK$65.20.  
- JD Health also received a Buy rating from TipRanks – PerPlexity's PerPlexity Health Care HK on March 8.  
- Conversely, TipRanks – xAI downgraded JD Health International, Inc. to a Hold on the same day.

JD Health International, Inc. (6618) Receives a Buy from Huatai Securities